The Ophthalmologist / Issues / 2021 / Jul / Ebb and Flow
Retina Research & Innovations Health Economics and Policy

Ebb and Flow

OCT angiography is being used to assess patients with sickle cell retinopathy before the disease progresses to irreversible vision loss

By Aleksandra Jones 7/5/2021 1 min read

Share

References

  1. DB Zhou et al., Biomedical Optics Express, 12, 2825 (2021). DOI: 10.1364/BOE.418874.

About the Author(s)

Aleksandra Jones

Having edited several technical publications over the last decade, I crossed paths with quite a few of Texere's current team members, and I only ever heard them sing the company's praises. When an opportunity arose to join Texere, I jumped at the chance! With a background in literature, I love the company's ethos of producing genuinely engaging content, and the fact that it is so well received by our readers makes it even more rewarding.

More Articles by Aleksandra Jones

Related Content

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: